SUMMARY The possible diagnostic value of an enlarged left atrial appendage (LAA) on the posterior-anterior or right anterior oblique chest film as a means of implicating a rheumatic etiology for mitral valve disease in children was investigated. Chest films were examined without prior knowledge of clinical or laboratory data, and the results were later correlated with this information in 113 children and adolescents. The clinical and laboratory data included application of the modified Jones criteria for the diagnosis of acute OVER THE PAST SEVERAL YEARS, it has been noted that a dilated left atrial appendage on the posterior-anterior (PA) chest film was frequently associated with rheumatic endocarditis of the mitral valve.' 2 This observation was based on experience with numerous cases of rheumatic and nonrheumatic disease of the mitral valve in both children and adults.3 Although the body of the left atrium often showed enlargement in patients with nonrheumatic mitral valve disease, the left atrial appendage (LAA) was rarely enlarged. This finding raised the possibility of using an enlarged LAA on radiologic examination as an adjunct in the diagnosis of rheumatic heart disease. Supporting data to validate this impression were therefore sought.
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Recently, the use of certain streptococcal antibody tests
[anti-streptolysin 0 (ASO), anti-desoxyribonuclease B (antiDNAse B), and anti-group A carbohydrate (A-antibody)] in distinguishing rheumatic from nonrheumatic mitral valve disease in children was refined.6"8 The presence of an elevated A-antibody with normal ASO and anti-DNAse B was recently reported in patients with rheumatic valvular disease but not in congenital mitral insufficiency. 6 The importance of correctly identifying those patients with mitral valve disease of rheumatic origin relates to the success of anti-streptococcal antibiotic prophylaxis in the prevention of recurrent rheumatic attacks. However, there is little advantage and significant risk in treating patients with mitral valve disease of nonrheumatic etiology in the same fashion. The risk includes both the potential hazard of anaphylactic reactions and the possible higher incidence of bacterial endocar-rheumatic fever, streptococcal antibody titers and clinical and cardiac catheterization findings.
In children with mitral valve disease, our data suggest that an enlarged LAA, especially in the presence of pulmonary venous obstruction, is characteristic of rheumatic heart disease. This finding appears to be particularly useful, in conjunction with streptococcal antibody studies, in distinguishing rheumatic from nonrheumatic patients with mitral insufficiency.
ditis with penicillin-resistant organisms in patients receiving oral penicillin.
With the availability of these streptococcal antibody tests for separating rheumatic from nonrheumatic mitral valve disease, this joint study was undertaken to determine the value of a dilated LAA in diagnosing the etiology of mitral valve disease. This communication reports the results of analysis of the radiologic finding of a dilated LAA as a means of implicating a rheumatic etiology for mitral valve disease in a group of 113 children and adolescents.
Material and Methods

Patients
The case material included 113 patients evaluated in the Rheumatic Fever Clinic at the University of Florida College of Medicine. Age, sex, and follow-up data are summarized in ASO and anti-DNAse B titers toward normal with persistence of elevated A-antibody titers, the pattern previously found to be associated with chronic rheumatic valvular disease.8
Group 2 consisted of seven patients without historical evidence of ARF who were referred for evaluation of possible rheumatic heart disease because of auscultatory findings of mitral insufficiency or stenosis. Two cases had aortic insufficiency as well. All seven showed elevated A-antibody levels in association with normal ASO and anti-DNAse B titers and were presumed to have rheumatic heart disease.
Group 3 consisted of 50 patients with nonrheumatic mitral valve disease. None of these patients manifested an acute illness fulfilling the modified Jones criteria. Thirtyeight patients had negative streptococcal antibody titers while 12 showed evidence of recent streptococcal infection, i.e., elevated ASO, anti-DNAse B titers and A-antibody levels. The titers in each of these 12 patients showed a nonrheumatic response, returning to normal within a year. Forty-nine of these patients had mitral insufficiency while one had mitral stenosis. The 50 patients in this group included 15 with endocardial cushion defects and mitral insufficiency, ten with mitral insufficiency associated with other congenital heart lesions. These included patent ductus arteriosus, atrial septal defect, ventricular septal defect, and congenital aortic valve lesions in varying combinations. Ten additional patients were asymptomatic, presented with mitral insufficiency without history of ARF, and had normal streptococcal antibody titers. Nine patients had mitral insufficiency shown to be associated with a prolapsing mitral leaflet, in six patients by right and left heart catheterization and angiocardiography and by echocardiographic documentation in the remaining three. Five patients had mitral insufficiency associated with myocardiopathy while one patient had congenital mitral stenosis associated with aortic stenosis and coarctation of the aorta. Thirty-nine of the 50 patients were studied by cardiac catheterization and angiography.
Group 4 consisted of 13 patients who fulfilled the modified Jones criteria for acute rheumatic fever but who had no evidence of cardiac involvement on initial presentation or during follow-up. All 13 patients had elevated streptococcal antibody titers with subsequent fall to normal.
Radiologic Analysis
In order to determine the significance of LAA enlargement in rheumatic heart disease, plain films were analyzed in the following manner. Chest films and/or cardiac series of the 113 patients of Groups 1-4 were randomized and evaluated independently by two cardiac radiologists without knowledge of clinical and laboratory information. A cardiac series included four views of the heart with barium in the esophagus. Analysis included assessment of the following parameters:
A. Pulmonary Vascularity. The pulmonary vascularity was determined to be normal or increased. Increased vascularity was characterized as either pulmonary venous obstruction (pulmonary venous hypertension or congestion) or shunt vascularity. Pulmonary venous obstruction (PVO) and shunt vascularity were further graded as mild, moderate, or severe depending on previously described and well-established criteria.1 B. Heart Size. The heart size was graded using a 0 to 4+ classification. Because of the variabilities inherent in a system employing exact measurements of heart size, the (table 4) . In the nine patients with normal vascularity, only two had an enlarged LAA. In both cases the LAA grading was initially l+ and returned to normal on subsequent follow-up exams. Two of the seven patients without evidence of LAA enlargement or PVO manifested enlargement of the body of the left atrium. Six of the seven had clinical evidence of very mild mitral insufficiency while one patient had predominant aortic insufficiency with minimal mitral insufficiency ( fig. 6 ).
Patients with Rheumatic Heart Disease Lacking Enlargement of LAA: False Negatives. Of the 12 patients with rheumatic heart disease without an enlarged LAA, seven showed normal vascularity and heart size. Six of these seven had very mild or transient mitral insufficiency while the seventh had predominant aortic insufficiency with minimal mitral insufficiency. Clinically, all seven of these patients were determined to have rheumatic heart disease of mild degree. Five rheumatic patients had negative LAA despite the presence of PVO. One had fulminant rheumatic carditis, massive pericardial effusion with a globular-shaped heart (fig. 7A), and died three days after hospitalization. Another patient had severe chronic mitral insufficiency and aortic insufficiency with probable pericardial effusion ( fig. 7B ), eventually requiring surgical replacement of the mitral and aortic valves; it is interesting to note that radiologic evidence of the LAA appeared transiently during the postoperative period. In both of these cases with pancarditis the LAA was hidden A B
by the pericardial effusion. The ability of a pericardial effusion to mask a dilated LAA is shown in figure 8 . 11) . Fortunately, these patients could be readily distinguished from patients with rheumatic mitral valve disease by the presence of shunt vascularity on plain film examination rather than evidence of PVO. Enlargement of the LAA in these two patients was likely related to the nonspecific hemodynamic effects of their severe mitral insufficiency and the consequent gross left atrial enlargement.
Size of Left Atrial Body. Thirty-five of the 50 patients with nonrheumatic mitral disease had radiographic enlargement of the body of the left atrium. This enlargement was graded as 1+ in 23 patients, 2+ in eight patients, and 3+ in four patients. This breakdown of left atrial body size is similar to the patients in Groups I and 2 with rheumatic or presumptive rheumatic heart disease. Both patients with nonrheumatic disease who manifested an enlarged LAA also had 3+ enlargement of the left atrial body.
Group 4 (13 patients)
Incidence ofLeft A trial Appendage Enlargement. Among the 13 patients with clinical and laboratory evidence of ARF without evidence of endocarditis, 12 had no evidence of LAA enlargement while one showed questionable enlargement of the LAA on two occasions four years apart. All other radiologic and clinical aspects of the cardiac exam were normal in this patient ( fig. 12) . No patients showed enlargement of the left atrium, cardiomegaly or abnormal pulmonary vascularity.
Discussion
It has been emphasized in recent studies that a significant proportion of mitral valve disease, especially in children, B may be of nonrheumatic etiology.6f 10-16 Differentiation of rheumatic from nonrheumatic disease in the young patient presenting with mitral valve disease without clear-cut history of ARF may be difficult. The usefulness of certain streptococcal antibody tests in aiding in this distinction has been suggested in a recent study.6 The present work was undertaken to determine whether a finding on plain chest film, namely enlargement of the left atrial appendage (LAA), might also be of use in this regard.
With few exceptions both the radiologic literature and textbook descriptions of the radiographic findings in rheumatic heart disease have failed to stress the possible diagnostic value of the dilated LAA.17 Some investigators have discussed the enlarged LAA in connection with the socalled mitral configuration, and have included LAA enlargement as a criterion for generalized left atrial enlargement. Kaye et al. 4 reported the presence of a dilated LAA in 41 of 100 adults and children with mitral valve stenosis alone and in combination with other valve lesions. He found it to be present in three cases of mitral stenosis without other radiological evidence of left atrial enlargement. The etiologic documentation in these patients is uncertain but assumed to be rheumatic. Jacobson and Weidner" stated that the dilated LAA was one of the most reliable manifestations of mitral valve disease, and suggested performance of the Valsalva maneuver as a means of making the LAA more visible. They theorized that the rheumatic process made the appendage more distensible than normal and, therefore, visible following release of the Valsalva maneuver. Interestingly, they encountered seven patients in whom demonstration of a temporarily dilated LAA was the only positive radiographic finding of mitral valve disease.
Two uncommon entities characterized by radiographic Our past experience has emphasized the fact that enlargement of the LAA has been rare to uncommon in the wide range of nonrheumatic cardiac lesions which can lead to enlargement of the body of the left atrium. The 50 patients in Group 3 with nonrheumatic mitral valve disease include a wide variety of lesions which may lead to left atrial enlargement. These include left-to-right shunts with intact atrial septum, endocardial cushion defects, congenital mitral insufficiency, nonobstructive myocardiopathy, prolapsing mitral valve and asymmetric septal hypertrophy. Only two of these 50 patients (4%) showed evidence of LAA enlargement, both cases associated with left-to-right shunts (figs. 9 and 10). These cases emphasize the importance of considering the nature of the radiologic changes in pulmonary vascularity in interpreting the presence of an enlarged LAA. Kaye reported a dilated LAA to be present in only one of 62 patients without heart disease4 while Jacobson and Weidner found only one false positive LAA in several hundred patients who had congenital and acquired nonrheumatic heart disease. ' Overall, the data presented indicate that there is a very good correlation between the presence of a dilated LAA and clinical and laboratory evidence of rheumatic mitral valve disease. This association is particularly striking when radiologic assessment of the pulmonary vascularity is considered. Left atrial appendage enlargement was found in 36 of 41 (88%) patients with rheumatic mitral disease severe enough to cause some degree of PVO. It was primarily in those patients with very mild or transient rheumatic mitral valve disease that the LAA was not frequently seen. In addition, there was excellent correlation between serial changes in the size of the LAA and the severity of mitral insufficiency as judged by clinical criteria and levels of streptococcal antibody titers. Among the seven patients (Group 2) presenting with mitral insufficiency without history of ARF but with a pattern of streptococcal antibodies similar to those previously described as characteristic of patients with chronic inactive rheumatic heart disease,"8-each manifested LAA enlargement. This finding further supports this radiologic criterion as an aid to the differentiation of rheumatic and nonrheumatic mitral disease.
The patients in Group 4 who had clinical and laboratory evidence of rheumatic fever without rheumatic endocarditis represent a group which essentially acts as normal controls. It is intriguing that one of these patients showed of the left atrium is deri"ed from the extracardiac common pulmonary vein.
The data presented here suggest that the finding of radiologic evidence of an enlarged LAA in a child with mitral valve disease, especially in association with evidence of PVO, is a reliable sign indicating a rheumatic etiology for the mitral valve disease.
